Healthcare >> CEO Interviews >> June 2, 2004

MARTIN GERSTEL – COMPUGEN LTD

MARTIN STEPHEN GERSTEL is Chairman of Compugen Ltd., a life science discovery company, and co-Founder/co-Chairman of Itamar Medical, a medical device company, both headquartered in Israel. Prior to relocating to Israel in 1994, Mr. Gerstel was the co-Chairman and CEO of ALZA Corporation, a pharmaceutical company based on advanced drug delivery mechanisms, where he had participated in the founding in 1968 and subsequently held a series of senior management positions including CFO, COO and CEO. ALZA was purchased by Johnson & Johnson in 2001. In addition to his activities with Compugen and Itamar Medical, Mr. Gerstel currently serves as a Director of Symyx Technologies and the Foundation for the National Medals of Science and Technology; is a member of the Board of Governors and the Executive Committee of the Weizmann Institute of Science and the Board of Governors of the Hebrew University, and is an Advisor to the Burrill Life Science Funds and the Board of the Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation. He also is a frequent lecturer and seminar leader in various areas of corporate management and strategy, negotiations and finance. Mr. Gerstel is a graduate of Yale University and the Stanford Graduate School of Business. Profile
TWST: Could you begin with a brief history of Compugen and a description

of your operation?

Mr. Gerstel: Compugen is a drug and diagnostic discovery company and is

a leader in incorporating